BI launches one-shot PCV2 vaccine for in Russia
Germany-based animal health company Boehringer Ingelheim announced that its one-shot vaccine against Porcine Circovirus 2 (PCV2) has now been granted market authorisation for Russia.
The vaccine is now being launched nationally in a series of meetings held across Russia during June.©
The vaccine is being launched just as Russia begins to further expand its pig industry, encouraged by support from the Russian government that aims at reducing or even eliminating the need for pork imports. Today, Russia produces more than two million tonnes of pork per year.
The vaccine has already been used successfully in 45 countries in Asia, the European Union, North America, South America, Oceania and Africa.©
Administration to pigs
The single-shot PCV2 vaccine can be administered to pigs around weaning, providing them with an efficient protection against clinical signs and economic damages due to porcine Circovirus diseases.
Essentially, almost 100 percent of pig herds are infected with the PCV2 virus. Acute infections with the virus compromise the immunity of the pigs, leading to high mortality rates, an increased frequency of co-infections with other pathogens and a poor growth performance.
Related website:
• Boehringer Ingelheim
Join 18,000+ subscribers
Subscribe to our newsletter to stay updated about all the need-to-know content in the pigsector, three times a week.
